Comparison of the Postoperative Analgesic Effectiveness of Erector Spinae Plane Block Versus Its Combination With Superficial Parasternal Intercostal Plane Block Within the ERACS Program
Key facts
- Who runs it
- Ankara University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 42 people enrolled
- Started
- 30 Aug 2024
- Ended
- 30 Jul 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Procedure: Erector Spinae Plane (ESP) Block
- Erector Spinae Plane (ESP) Block + Superficial Parasternal Intercostal Plane (SPIP) Block
- Record updated
- 31 December 2025
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Patients scheduled for elective cardiac surgery via median sternotomy under the ERACS protocol
- Age between 18 and 80 years
- ASA physical status II-III
- Body Mass Index (BMI) between 18 and 35 kg/m²
- No cognitive impairment (able to cooperate and follow commands)
- No history of chronic pain or regular analgesic use
- Provided written informed consent after detailed explanation of the study
Who cannot take part
- Emergency surgery
- Redo coronary artery bypass surgery
- Chronic pain or opioid use prior to surgery
- Pre-existing cognitive disorder or psychiatric illness affecting pain or delirium evaluation
- Infection or skin lesion at the injection site
- Known allergy or hypersensitivity to local anesthetics (bupivacaine or amide type)
- Age < 18 years or > 80 years
- ASA physical status ≥ IV
- Pregnant or breastfeeding women
- Unwillingness to participate or withdrawal of consent at any stage
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective, randomized, double-blind, parallel-group clinical trial within the Enhanced Recovery After Cardiac Surgery (ERACS) program compares postoperative analgesic effectiveness of bilateral erector spinae plane (ESP) block versus ESP combined with superficial parasternal intercostal plane (SPIP) block in adult patients undergoing elective cardiac surgery via median sternotomy.
The 2 groups in the trial
- Arm 1: Erector Spinae Plane Block (Group E)Treatment being tested
After induction of general anesthesia, patients will receive a bilateral ultrasound-guided erector spinae plane block at the T4--T5 vertebral level. A total of 30 mL of 0.25% bupivacaine per side (prepared as 10 mL saline + 10 mL 0.5% bupivacaine per syringe) will be injected into the deep fascial plane beneath the erector spinae muscle using an 80 mm block needle under aseptic conditions. The spread of the local anesthetic will be observed in a craniocaudal direction in real time. The procedure will be repeated bilaterally. All patients will subsequently receive standardized postoperative analgesia with paracetamol 1 g IV every 6 hours; if VAS \> 4, tramadol 50 mg IV will be given as rescue analgesia.
Treatment: Procedure: Erector Spinae Plane (ESP) Block
- Erector Spinae Plane Block + Superficial Parasternal Intercostal Plane Block (Group EP)Existing treatment, for comparison
Following induction of general anesthesia, patients will receive a bilateral ESP block (same technique as in Group E) with 20 mL of 0.25% bupivacaine per side. Afterward, a bilateral superficial parasternal intercostal plane block (SPIP) will be performed in the 4th-5th intercostal spaces, approximately 2-3 cm lateral to the midline, using a linear ultrasound probe and 80 mm block needle. After confirming negative aspiration and hydrodissection with 1-3 mL saline, 10 mL of 0.25% bupivacaine per side will be injected into the interfacial plane. The total local anesthetic volume for both blocks combined will be 60 mL, kept below the toxic threshold. Standard postoperative analgesia will be identical to Group E (paracetamol 1 g IV every 6 hours, and tramadol 50 mg IV if VAS \> 4).
Treatment: Erector Spinae Plane (ESP) Block + Superficial Parasternal Intercostal Plane (SPIP) Block
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of Postoperative Analgesic Effectiveness of Erector Spinae Plane Block and Combined With Superficial Parasternal Intercostal Plane Block Within the Enhanced Recovery After Cardiac Surgery (ERACS) Program: A Prospective, Randomized, Double-Blind Study
- Record updated
- 31 December 2025